37 related articles for article (PubMed ID: 19937566)
1. [Hospital hygiene 2.0 : Cross-interface, molecular epidemiological early warning systems for prevention of multidrug-resistant pathogens].
Schwerdtner NL; Kipp F
Urologe A; 2020 Nov; 59(11):1407-1416. PubMed ID: 33078262
[TBL] [Abstract][Full Text] [Related]
2. MRSA Prevalence and Risk Factors among Health Personnel and Residents in Nursing Homes in Hamburg, Germany - A Cross-Sectional Study.
Peters C; Dulon M; Kleinmüller O; Nienhaus A; Schablon A
PLoS One; 2017; 12(1):e0169425. PubMed ID: 28068356
[TBL] [Abstract][Full Text] [Related]
3. Multiresistant pathogens in geriatric nursing - infection control in residential facilities for geriatric nursing in Germany.
Peters C; Schablon A; Bollongino K; Maaß M; Kaß D; Dulon M; Diel R; Nienhaus A
GMS Hyg Infect Control; 2014; 9(3):Doc22. PubMed ID: 25285266
[TBL] [Abstract][Full Text] [Related]
4. One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010.
Wegner C; Hübner NO; Gleich S; Thalmaier U; Krüger CM; Kramer A
GMS Hyg Infect Control; 2013; 8(1):Doc12. PubMed ID: 23967398
[TBL] [Abstract][Full Text] [Related]
5. On the economic impact of a regional management of multidrug-resistant bacteria.
Ried W
GMS Krankenhhyg Interdiszip; 2011; 6(1):Doc23. PubMed ID: 22242104
[TBL] [Abstract][Full Text] [Related]
6. HIC@RE … and its relevance for a company like RIEMSER.
Müller B; Becker J
GMS Krankenhhyg Interdiszip; 2011; 6(1):Doc22. PubMed ID: 22242103
[TBL] [Abstract][Full Text] [Related]
7. [On the economic burden of MRSA in Germany].
Claus F; Sachse A; Ried W
Gesundheitswesen; 2014 Dec; 76(12):800-6. PubMed ID: 25372655
[TBL] [Abstract][Full Text] [Related]
8. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
[TBL] [Abstract][Full Text] [Related]
9. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
Gould IM; Reilly J; Bunyan D; Walker A
Clin Microbiol Infect; 2010 Dec; 16(12):1721-8. PubMed ID: 20825434
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
[TBL] [Abstract][Full Text] [Related]
12. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals.
Resch A; Wilke M; Fink C
Eur J Health Econ; 2009 Jul; 10(3):287-97. PubMed ID: 19015905
[TBL] [Abstract][Full Text] [Related]
13. [Economic aspects of the management and control of MRSA].
Hübner NO; Hübner C; Kramer A
Gesundheitswesen; 2009 Nov; 71(11):771-6. PubMed ID: 19937566
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
